MarkMHuyckeMD
Infectious Disease • Oklahoma City, OKClinical Professor, Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Dr. Huycke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1200 Everett Dr
6e238
Oklahoma City, OK 73104Phone+1 405-271-6434
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Infectious Disease, 1985 - 1989
University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1982 - 1985
University of Kansas School of MedicineClass of 1982
Certifications & Licensure
OK State Medical License 1983 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Frances Duffy Endowed Chair OUHSC, 1996-2018
- Fellow (IDSA) Infectious Diseases Society of America, 1999
- Fellow (FACP) American College of Physicians, 1999
Publications & Presentations
PubMed
- 106 citationsAdenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort studyBassam Ghabach, William F. Anderson, Rochelle E. Curtis, Mark M. Huycke, Jackie A. Lavigne
Breast Cancer Research. 2010-07-23 - 444 citationsMultiple-drug resistant enterococci: the nature of the problem and an agenda for the future.Mark M. Huycke, Daniel F. Sahm, Michael S. Gilmore
Emerging Infectious Diseases. 1998-04-01 - 337 citationsVariable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteriaSandra C. Kim, Susan L. Tonkonogy, Carol A. Albright, Julia Tsang, Edward Balish
Gastroenterology. 2005-04-01
Press Mentions
Researchers at OU Medicine Studying Possible Link Between Bacteria, Colon CancerJune 7th, 2019
Researcher Earns $2.3 Million Grant to Study Bacteria’s Role in Triggering Colon CancerJune 5th, 2019
Study Identifies How Enterococcus Faecalis Bacteria Causes Antibiotic Resistant InfectionApril 17th, 2019- Join now to see all
Grant Support
- Microbiome-triggered reprogramming and mutation of colon epithelial cells leading to tumor stem-like cellsNCI2019–2024
- Enterococcus Faecalis, Colorectal Cancer, And Bystander EffectsNational Cancer Institute2008–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
